Darrell H. Brookstein
Plus aucun poste en cours
Profil
Darrell H.
Brookstein worked as a Director at CAG Capital, Inc. from 2008 to 2010.
He was also the Managing Director at The Nanotech Co. LLC.
Brookstein served as Secretary, Director & Executive Vice President at Stellar Biotechnologies, Inc. from 2008 to 2013.
He was the President at First Georgetown Securities, Inc. Brookstein also worked as the Executive Vice President-Financial & Business at Stellar Biotechnologies, Inc. in 2010.
Brookstein completed his undergraduate degree from Duke University in 1973.
Anciens postes connus de Darrell H. Brookstein
Sociétés | Poste | Fin |
---|---|---|
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Directeur/Membre du Conseil | 21/06/2013 |
CAG Capital, Inc.
CAG Capital, Inc. Financial ConglomeratesFinance CAG Capital Inc. is a capital pool company. The company's principal business is to identify and evaluate businesses and assets and, once identified and evaluated, to negotiate an acquisition subject to receipt of the approval of the TSX venture exchange. The company has not conducted commercial operations other than to enter into discussions for the purpose of identifying potential acquisitions or interest. | Directeur/Membre du Conseil | 20/04/2010 |
Stellar Biotechnologies, Inc. /Old/ | Corporate Officer/Principal | 20/04/2010 |
First Georgetown Securities, Inc.
First Georgetown Securities, Inc. Investment Banks/BrokersFinance First Georgetown Securities, Inc. operates as a wealth management and brokerage firm. It offers portfolio management, securities trading, financial planning, investment banking, and advisory services. The company was founded 1975 and is headquartered in Alexandria, VA. | President | - |
The Nanotech Co. LLC | Corporate Officer/Principal | - |
Formation de Darrell H. Brookstein
Duke University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 5 |
---|---|
First Georgetown Securities, Inc.
First Georgetown Securities, Inc. Investment Banks/BrokersFinance First Georgetown Securities, Inc. operates as a wealth management and brokerage firm. It offers portfolio management, securities trading, financial planning, investment banking, and advisory services. The company was founded 1975 and is headquartered in Alexandria, VA. | Finance |
CAG Capital, Inc.
CAG Capital, Inc. Financial ConglomeratesFinance CAG Capital Inc. is a capital pool company. The company's principal business is to identify and evaluate businesses and assets and, once identified and evaluated, to negotiate an acquisition subject to receipt of the approval of the TSX venture exchange. The company has not conducted commercial operations other than to enter into discussions for the purpose of identifying potential acquisitions or interest. | Finance |
Stellar Biotechnologies, Inc. /Old/ | Health Technology |
The Nanotech Co. LLC | |
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |